ALLK – Allakos Inc
Allakos Inc.ALLK
$0.8555Name : Allakos Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $76,433,448.00
EPSttm : -2.03
Allakos Inc.
$0.8555
5.99%$0.0545Float Short %
1.04
Margin Of Safety %
Put/Call OI Ratio
0.09
EPS Next Q Diff
0.04
EPS Last/This Y
0.66
EPS This/Next Y
0.84
Price
0.85
Target Price
3.35
Analyst Recom
2.2
Performance Q
29.94
Relative Volume
4.29
Beta
0.85
Ticker: ALLK
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2024-12-19 | ALLK | 1.285 | 0.06 | 0.00 | 13775 |
| 2024-12-20 | ALLK | 1.215 | 0.06 | 0.75 | 14117 |
| 2024-12-23 | ALLK | 1.285 | 0.01 | 0.00 | 9618 |
| 2024-12-24 | ALLK | 1.27 | 0.01 | 0.15 | 9668 |
| 2024-12-26 | ALLK | 1.27 | 0.01 | 0.17 | 9729 |
| 2024-12-27 | ALLK | 1.295 | 0.02 | 1.37 | 9702 |
| 2024-12-30 | ALLK | 1.19 | 0.06 | 0.00 | 10118 |
| 2024-12-31 | ALLK | 1.21 | 0.06 | 0.00 | 10118 |
| 2025-01-02 | ALLK | 1.235 | 0.06 | 0.00 | 10121 |
| 2025-01-03 | ALLK | 1.16 | 0.06 | 999.99 | 10128 |
| 2025-01-06 | ALLK | 1.04 | 0.06 | 84.29 | 10139 |
| 2025-01-07 | ALLK | 1.025 | 0.13 | 1.00 | 10731 |
| 2025-01-08 | ALLK | 0.9683 | 0.13 | 0.00 | 10733 |
| 2025-01-09 | ALLK | 0.9792 | 0.13 | 0.00 | 10733 |
| 2025-01-10 | ALLK | 0.9625 | 0.13 | 0.00 | 10758 |
| 2025-01-13 | ALLK | 0.8778 | 0.13 | 0.41 | 10738 |
| 2025-01-14 | ALLK | 0.87 | 0.11 | 0.24 | 9790 |
| 2025-01-15 | ALLK | 0.8728 | 0.11 | 0.24 | 9790 |
| 2025-01-16 | ALLK | 0.9146 | 0.10 | 0.00 | 8669 |
| 2025-01-17 | ALLK | 0.8449 | 0.09 | 0.00 | 9094 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2024-12-19 | ALLK | 1.28 | 72.1 | - | -1.51 |
| 2024-12-20 | ALLK | 1.22 | 72.1 | - | -1.51 |
| 2024-12-23 | ALLK | 1.29 | 72.1 | - | -1.48 |
| 2024-12-24 | ALLK | 1.27 | 75.0 | - | -1.48 |
| 2024-12-26 | ALLK | 1.26 | 75.0 | - | -1.48 |
| 2024-12-27 | ALLK | 1.29 | 75.0 | - | -1.48 |
| 2024-12-30 | ALLK | 1.19 | 75.0 | - | -1.48 |
| 2024-12-31 | ALLK | 1.21 | 75.0 | - | -1.48 |
| 2025-01-02 | ALLK | 1.24 | 75.0 | - | -1.48 |
| 2025-01-03 | ALLK | 1.15 | 75.0 | - | -1.48 |
| 2025-01-06 | ALLK | 1.08 | 75.0 | - | -1.48 |
| 2025-01-07 | ALLK | 1.02 | 75.0 | - | -1.48 |
| 2025-01-08 | ALLK | 0.98 | 75.0 | - | -1.48 |
| 2025-01-09 | ALLK | 0.98 | 75.0 | - | -1.48 |
| 2025-01-10 | ALLK | 0.97 | 75.0 | - | -1.48 |
| 2025-01-13 | ALLK | 0.87 | 75.0 | - | -1.48 |
| 2025-01-14 | ALLK | 0.87 | 75.0 | - | -1.48 |
| 2025-01-15 | ALLK | 0.87 | 75.0 | - | -1.48 |
| 2025-01-16 | ALLK | 0.92 | 75.0 | - | -1.48 |
| 2025-01-17 | ALLK | 0.85 | 75.0 | - | -1.48 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2024-12-19 | ALLK | -0.70 | -10.62 | 1.30 |
| 2024-12-20 | ALLK | -0.70 | -10.62 | 1.30 |
| 2024-12-23 | ALLK | -0.76 | -10.62 | 1.30 |
| 2024-12-24 | ALLK | -0.76 | -10.62 | 1.30 |
| 2024-12-26 | ALLK | -0.72 | -10.62 | 1.09 |
| 2024-12-27 | ALLK | -0.70 | -10.62 | 1.09 |
| 2024-12-30 | ALLK | -0.68 | -10.94 | 1.09 |
| 2024-12-31 | ALLK | -0.68 | -10.94 | 1.09 |
| 2025-01-02 | ALLK | -0.69 | -10.94 | 1.09 |
| 2025-01-03 | ALLK | 0.00 | -10.94 | 1.09 |
| 2025-01-06 | ALLK | 0.00 | -10.72 | 1.09 |
| 2025-01-07 | ALLK | 0.00 | -10.72 | 1.09 |
| 2025-01-08 | ALLK | 0.00 | -10.72 | 1.09 |
| 2025-01-09 | ALLK | 0.00 | -10.72 | 1.09 |
| 2025-01-10 | ALLK | 0.00 | -10.72 | 1.09 |
| 2025-01-13 | ALLK | 0.00 | -10.72 | 1.04 |
| 2025-01-14 | ALLK | 0.00 | -10.72 | 1.04 |
| 2025-01-15 | ALLK | 0.00 | -10.72 | 1.04 |
| 2025-01-16 | ALLK | 0.00 | -10.72 | 1.04 |
| 2025-01-17 | ALLK | 0.00 | -10.72 | 1.04 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.21
Avg. EPS Est. Current Quarter
-0.18
Avg. EPS Est. Next Quarter
-0.17
Insider Transactions
Institutional Transactions
-10.72
Beta
0.85
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
3
Growth Score
21
Sentiment Score
29
Actual DrawDown %
99.5
Max Drawdown 5-Year %
-99.6
Target Price
3.35
P/E
Forward P/E
PEG
P/S
P/B
1.05
P/Free Cash Flow
EPS
-2.03
Average EPS Est. Cur. Y
-1.48
EPS Next Y. (Est.)
-0.64
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
4.29
Return on Equity vs Sector %
-264.8
Return on Equity vs Industry %
-252.2
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
Allakos Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 131
Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.
stock quote shares ALLK – Allakos Inc Stock Price stock today
news today ALLK – Allakos Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch ALLK – Allakos Inc yahoo finance google finance
stock history ALLK – Allakos Inc invest stock market
stock prices ALLK premarket after hours
ticker ALLK fair value insiders trading